RPN2 is an important molecular marker in various cancers and has been associated with drug resistance in solid cancers, including breast cancer [12], oesophageal squamous cell carcinoma [43], non-small-cell lung cancer [8], and gastric cancer [44]. Here, RPN2 is linked to breast carcinoma.